AmideBio LLC, a privately-held biopharmaceutical company, announced today that it has closed a new private placement round of $764,000 of preferred equity financing. The proceeds will be used to further …
AMIDEBIO awarded NIH grant for hyperinsulinism program
AmideBio LLC, a biopharmaceutical company in Boulder that makes peptides used in research to discover therapies for diabetes, has received a $338,387 grant that it will use to further develop …
- Page 2 of 2
- 1
- 2